« Back to Record
Fumagalli, D., Venet, D., Ignatiadis, M., Abdel Azim, H. H., Maetens, M. M., Rothé, F., Salgado, R., Bradbury, I., Pusztai, L., Harbeck, N., Gomez, H., Chang, T.-W., Coccia-Portugal, M., Di Cosimo, S., de Azambuja, E., de la Peña, L., Nuciforo, P., Brase, J. J., Huober, J., Baselga, J., Piccart-Gebhart, M., Loi, S., & Sotiriou, C. (2017). RNA Sequencing to Predict Response to Neoadjuvant Anti-HER2 Therapy: A Secondary Analysis of the NeoALTTO Randomized Clinical Trial. JAMA oncology, 3(2), 227-234. doi:10.1001/jamaoncol.2016.3824
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/241920



